Randomized, Double-Blind, Placebo-Controlled, Phase I, Dose- Escalation Study to Evaluate the Tolerance, Pharmacokinetics, Pharmacodynamics and Immunogenicity of PEGylated Urate Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers: Study Protocol

Randomized, Double-Blind, Placebo-Controlled, Phase I, Dose- Escalation Study to Evaluate the Tolerance, Pharmacokinetics, Pharmacodynamics and Immunogenicity of PEGylated Urate Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers: Study Protocol

Feifei Sun,1,* Chenjing Wang,1,* Yi Xu,1 Pingping Lin,1 Yaozhong Cao,2 Jiahui Zhang,3 Xin Li,1 Xin Jiang,1 Yao Fu,1 Yu Cao1 1Clinical Trials Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People’s Republic of China; 2Clinical Medical Center, Xiuzheng Pharma...

Full description

Bibliographic Details
Main Authors: Sun F, Wang C, Xu Y, Lin P, Cao Y, Zhang J, Li X, Jiang X, Fu Y
Format: Article
Language:English
Published: Dove Medical Press 2023-12-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
pegylated urate oxidase
healthy volunteers
patients with hyperuricemia
study protocol
Online Access:https://www.dovepress.com/randomized-double-blind-placebo-controlled-phase-i-dose--escalation-st-peer-reviewed-fulltext-article-DMSO

Internet

https://www.dovepress.com/randomized-double-blind-placebo-controlled-phase-i-dose--escalation-st-peer-reviewed-fulltext-article-DMSO

Similar Items